ADAR and liver cancer: These results showed that ADAR1 editing of canonical miR-3144-3p caused off-target effects on MSI2 expression, and in contrast, the newly created ED_miR-3144(3_A < G) mutant inhibited the expression of a different target, namely, SLC38A4, contributing to liver cancer.